Volume 94 Issue 47 | p. 15 | Concentrates
Issue Date: November 28, 2016

Grant from Texas prompts biotech to move

Department: Business
Keywords: oncology, Texas, acute myelogenous leukemia

The biotech firm Ruga Corp. has changed its name to Aravive Biologics and moved from Palo Alto, Calif., to Houston after receiving a $20 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The product of a 2007 state constitutional amendment, CPRIT has to date awarded $1.7 billion to Texas researchers. Aravive will be based at the Texas Medical Center, where it will develop Aravive-S6, a fusion protein designed to block a signaling pathway active in acute myelogenous leukemia.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment